Times are Smoking Hot! – BAT to Acquire the Remaining Stake in Reynolds for $47bn

British American Tobacco Plc. (BATS)—market cap as of 28/10/16: £87.26bn Reynolds American, Inc. (RAI)—market cap as of 28/10/16: $78.16bn Introduction On October 21, 2016, British American Tobacco (“BAT”) delivered a non-binding merger proposal to Reynolds American Inc. (“Reynolds”). Through this $47bn deal, BAT will acquire the remaining 57.8% of Reynolds’ Read more…

Tireless Shire: Another Deal in Pharma M&A Wave

Shire PLC; market cap: $28.38bn (as of 06/11/2015) Dyax Corporation; market cap: $5.1bn (as of 06/11/2015)   Introduction On November 2, Dublin-headquartered pharmaceutical company Shire Plc agreed to acquire the Massachusetts-based biopharma company Dyax Corporation for an upfront cash consideration of $5.9bn and an additional $646m payment contingent on the Read more…

Valeant, the serial pharma dealmaker cuts again

Valeant Pharmaceuticals International, Inc.; market cap (as of 26/02/2015): US$76.68bn Salix Pharmaceuticals, Ltd.; market cap (as of 26/02/2015): US$10.07bn     Introduction The pharmaceutical industry has undergone an intense period of consolidation in the past 18 months which is far from over as the big players take advantage of the Read more…